Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?

Lars Vedel Kessing

doi:10.1080/08039488.2021.2008000

Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?

3 Citationer (Scopus)

Originalsprog	Engelsk
Tidsskrift	Nordic Journal of Psychiatry
Vol/bind	76
Udgave nummer	7
Sider (fra-til)	487-488
Antal sider	2
ISSN	0803-9488
DOI	https://doi.org/10.1080/08039488.2021.2008000
Status	Udgivet - okt. 2022

Adgang til dokumentet

10.1080/08039488.2021.2008000

Andre filer og links

Link to publication in Scopus

Citationsformater

@article{7a307476ea6d48f59617f04fe0eac52f,

title = "Should long-acting injectable antipsychotics be used earlier and more frequent in bipolar disorder, type I?",

keywords = "Antipsychotic Agents/adverse effects, Bipolar Disorder/drug therapy, Delayed-Action Preparations/therapeutic use, Humans, Risperidone/therapeutic use",

author = "Kessing, {Lars Vedel}",

year = "2022",

month = oct,

doi = "10.1080/08039488.2021.2008000",

language = "English",

volume = "76",

pages = "487--488",

journal = "Nordic Journal of Psychiatry",

issn = "0803-9488",